Irbesartan Tablet
Product Images NDC 62135-976

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 62135-976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Irbesartan Tablets 150mg 90s Bottle Label)

FDA Label Image

"image Description" (Irbesartan Tablets 300mg 90s Bottle Label)

FDA Label Image

"image Description" (Irbesartan Tablets 75mg 90s Bottle Label)

FDA Label Image

"image Description" (Irbesartan Tablets Graph 1)

"image Description" (Irbesartan Tablets Graph 1)
This is a visualization comparing placebo-subtracted reduction in trough SeSBP and SeDBP for different doses of Irbesartan (mg/day). The dataset includes values at 150, 300, 450, 600, 750, and 900 mg/day. This information could be helpful for assessing the effectiveness of Irbesartan at different dosages in reducing blood pressure.*
FDA Label Image

"image Description" (Irbesartan Tablets Graph 2)

"image Description" (Irbesartan Tablets Graph 2)
This text provides information on the cumulative event rate (%) for AVAPRO AR, Amlodipine, and Placebo over 60 months of follow-up. It shows the rates throughout the duration and is likely part of a clinical study or trial comparing the effectiveness of these medications.*
FDA Label Image

"image Description" (Irbesartan Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.